Efficacy and Influencing Factors of Secukinumab in Patients With Axial Spondyloarthritis

Clinical trial NCT07130331 · COMPLETED

Trial details

NCT number: NCT07130331
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status: COMPLETED
Study type: OBSERVATIONAL

Axial Spondylarthritis (axSpA)Secukinumab

Start date: 2020-06-01
Primary completion: 2024-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.